Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Critical Care ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis.Lancet. 2002; 360: 1131-1135
- Should we remain reluctant to admit critically ill cancer patients to the intensive care unit?.in: Vincent J.-L. Yearbook of intensive care and emergency medicine. Springer-Verlag, Berlin/Heidelberg/New York2009: 845-855
- Clinical review: specific aspects of acute renal failure in cancer patients.Crit Care. 2006; 10: 211
- Is intensive care justified for patients with haematological malignancies?.Intensive Care Med. 1990; 16: 291-297
- Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors.Swiss Med Wkly. 2001; 131: 681-686
- Hemodialysis for acute renal failure in patients with hematologic malignancies.Crit Care Med. 1991; 19: 346-351
- The intensive care support of patients with malignancy: do everything that can be done.Intensive Care Med. 2006; 32: 3-5
- Can we still refuse ICU admission of patients with hematological malignancies?.Intensive Care Med. 2008; 34: 790-792
- Multiple organ failure and outcome of critically ill patients with haematological malignancy.Acta Anaesthesiol Scand. 2003; 47: 301-306
- Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies.Intensive Care Med. 2002; 28: 1294-1300
- Intensive care, mechanical ventilation, dialysis, and cardiopulmonary resuscitation. Implications for the patient with cancer.Crit Care Clin. 2001; 17 (x): 791-803
- Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies.Nephrol Dial Transplant. 2005; 20: 552-558
- Continuous venovenous haemofiltration in cancer patients with renal failure: a single-centre experience.Support Care Cancer. 2004; 12: 306-311
- Should dialysis be offered to cancer patients with acute kidney injury?.Intensive Care Med. 2007; 33: 765-772
- Prognosis of critically ill patients with cancer and acute renal dysfunction.J Clin Oncol. 2006; 24: 4003-4010
- Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support.Crit Care Med. 2001; 29: 519-525
- Predictors of short-term mortality in critically ill patients with solid malignancies.Intensive Care Med. 2000; 26: 1817-1823
- Changing use of intensive care for hematological patients: the example of multiple myeloma.Intensive Care Med. 1999; 25: 1395-1401
- The prognosis of acute respiratory failure in critically ill cancer patients.Medicine (Baltimore). 2004; 83: 360-370
- Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome.Intensive Care Med. 2005; 31: 934-942
- Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication.Crit Care Med. 2003; 31: 104-112
- Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure.Chest. 2004; 126: 1299-1306
- Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU.Intensive Care Med. 2006; 32: 1560-1568
- Improved survival of critically ill cancer patients with septic shock.Intensive Care Med. 2003; 29: 1688-1695
- Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period.Eur J Cancer. 2003; 39: 783-792
- Continued survival gains in recent years among critically ill myeloma patients.Intensive Care Med. 2009; 35: 512-518
- Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit.Crit Care Med. 2008; 36: 690-696
- Effect of age on survival of critically ill patients with cancer.Crit Care Med. 2006; 34: 715-721
- Prognosis of lung cancer patients with life-threatening complications.Chest. 2007; 131: 840-846
- Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs.Crit Care Med. 2005; 33: 520-526
- Outcomes and prognostic factors in patients with head and neck cancer and severe acute illnesses.Intensive Care Med. 2007; 33: 2009-2013
- Characteristics and outcomes of cancer patients in European ICUs.Crit Care. 2009; 13: R15
- Case volume and mortality in haematological patients with acute respiratory failure.Eur Respir J. 2008; 32: 748-754
- Short- and long-term outcomes of critically ill patients with cancer and prolonged ICU length of stay.Chest. 2008; 134: 520-526
- Resource use and outcome in critically ill patients with hematological malignancy: a retrospective cohort study.Crit Care. 2008; 12: R75
- Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care.Eur J Haematol. 2005; 74: 511-516
- Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.Intensive Care Med. 2008; 34: 847-855
- Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.Intensive Care Med. 2006; 32: 93-99
- Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy.Crit Care Med. 2005; 33: 2488-2493
- Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation.Blood. 2001; 98: 3234-3240
- Acute renal failure in bone marrow transplant patients admitted to the intensive care unit.Nephron. 2002; 90: 408-412
- Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.J Clin Oncol. 2006; 24: 643-649
- Effect of acute kidney injury on weaning from mechanical ventilation in critically ill patients.Crit Care Med. 2007; 35: 184-191
- Acute renal failure in hematopoietic cell transplantation.Kidney Int. 2006; 69: 430-435
- Acute renal failure— definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.Crit Care. 2004; 8: R204-R212
- Epidemiology of acute kidney injury: how big is the problem?.Crit Care Med. 2008; 36: S146-S151
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.Crit Care. 2007; 11: R31
- Defining and classifying AKI: one set of criteria.Nephrol Dial Transplant. 2008; 23: 1471-1472
- Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units.Crit Care. 2007; 11: R68
- Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study.Crit Care. 2005; 9: R700-R709
- Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score.Intensive Care Med. 2000; 26: 915-921
- Acute renal failure in critically ill patients: a multinational, multicenter study.JAMA. 2005; 294: 813-818
- Life-sustaining treatments in patients who died of chronic congestive heart failure compared with metastatic cancer.Crit Care Med. 2003; 31: 60-64
- Prognostic stratification in critically ill patients with acute renal failure requiring dialysis.Arch Intern Med. 1995; 155: 1505-1511
- Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome.J Am Soc Nephrol. 2003; 14: 1022-1030
- Impact of two different comorbidity measures on the 6-month mortality of critically ill cancer patients.Intensive Care Med. 2005; 31: 408-415
- Prognosis of hematologic malignancies does not predict intensive care unit mortality.Crit Care Med. 2002; 30: 2260-2270
- Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines.Ann Intern Med. 1996; 125: 625-633
- Bisphosphonates: mechanism of action and role in clinical practice.Mayo Clin Proc. 2008; 83: 1032-1045
- Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies: reply to letter by Meyer et al.Intensive Care Med. 2008; 34: 1930-1931
- Early goal-directed therapy in the treatment of severe sepsis and septic shock.N Engl J Med. 2001; 345: 1368-1377
- Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure.N Engl J Med. 2001; 344: 481-487
- Efficacy and safety of recombinant human activated protein C for severe sepsis.N Engl J Med. 2001; 344: 699-709
- Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure.Crit Care Med. 2005; 33: 341-348
- Distribution patterns of microthrombi in disseminated intravascular coagulation.Arch Pathol Lab Med. 1983; 107: 543-547
- Role of protein C in renal dysfunction after polymicrobial sepsis.J Am Soc Nephrol. 2007; 18: 860-867
- Soluble thrombomodulin protects ischemic kidneys.J Am Soc Nephrol. 2009; 20: 524-534
- 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.Clin Infect Dis. 2002; 34: 730-751
- Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.BMJ. 2004; 328: 668
- Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.BMJ. 2003; 326: 1111
- Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.Cochrane Database Syst Rev. 2006; 3 (CD002009)
- Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.Am J Health Syst Pharm. 2009; 66: 82-98
- High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.Arch Intern Med. 2006; 166: 2138-2144
- Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.Antimicrobial Agents Chemother. 2008; 52: 1330-1336
- Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled.BMJ. 2001; 322 ([Clinical research ed.]): 579
- Management of invasive candidiasis in critically ill patients.Drugs. 2004; 64: 2159-2175
- Contrast-induced acute kidney injury.J Am Coll Cardiol. 2008; 51: 1419-1428
- Pathophysiology of contrast-induced nephropathy.Am J Cardiol. 2006; 98: 14K-20K
- Multiple myeloma and contrast media.Radiology. 1992; 183: 519-521
- Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.JAMA. 2004; 291: 2328-2334
- Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis.Nephrol Dial Transplant. 2009; ([Epub ahead of print])
- N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses.Am Heart J. 2007; 153: 275-280
- The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable.J Am Soc Nephrol. 2004; 15: 407-410
- Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.Am J Med. 2006; 119: 155-162
- Cisplatin nephrotoxicity.Semin Nephrol. 2003; 23: 460-464
- 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.J Clin Oncol. 2002; 20: 2895-2903
- Understanding and managing methotrexate nephrotoxicity.Oncologist. 2006; 11: 694-703
- Late-onset delayed excretion of methotrexate.Cancer Chemother Pharmacol. 2004; 54: 146-152
- Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.Br J Cancer. 2005; 92: 480-487
- Tumour lysis syndrome: new therapeutic strategies and classification.Br J Haematol. 2004; 127: 3-11
- Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.Am J Med. 2004; 116: 546-554
- Acute tumor lysis syndrome: diagnosis and management.in: Vincent J.-L. Yearbook of intensive care and emergency medicine. Springer-Verlag, Berlin/Heidelberg/New York2009: 819-827
- Disseminated intravascular coagulation in cancer patients.Best Pract Res Clin Haematol. 2009; 22: 129-136
- Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.Thromb Haemost. 2001; 86: 828-833
- The coagulopathy of acute promyelocytic leukaemia revisited.Best Pract Res Clin Haematol. 2009; 22: 153-163
- Trousseau's syndrome. Devastating coagulopathy in the absence of heparin.Am J Med. 1985; 79: 423-430
- Trousseau's syndrome.West J Med. 1993; 158: 364-371
- Multiple organ failure without sepsis following surgical treatment of advanced gastric carcinoma.Jpn J Surg. 1988; 18: 705-708
- Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features.Medicine (Baltimore). 1977; 56: 1-37
- First-ever stroke as initial presentation of systemic cancer.J Stroke Cerebrovasc Dis. 2008; 17: 169-174
- Trousseau's syndrome: multiple definitions and multiple mechanisms.Blood. 2007; 110: 1723-1729
- Disseminated intravascular coagulation (DIC) and non-small cell lung cancer (NSCLC): report of a case and review of the literature.Lung Cancer. 2009; 64: 247-249
- Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.Ann Hematol. 2008; 87: 451-457
- Disseminated intravascular coagulation and stroke associated with cervical cancer.J Stroke Cerebrovasc Dis. 1999; 8: 355-357
- Marantic endocarditis and disseminated intravascular coagulation with systemic emboli in presentation of pancreatic cancer.J Clin Oncol. 2008; 26: 1383-1385
- Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.J Clin Oncol. 1989; 7: 781-789
- Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and a systematic review of published cases.Oncologist. 2007; 12: 11-19
- Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients.J Hematol Oncol. 2008; 1: 23
- Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome.Epidemiology. 2004; 15: 208-215
- Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer.Oncologist. 2003; 8: 375-380
- Purpura in a patient with disseminated breast cancer: a rapidly progressive cancer-related thrombotic thrombocytopenic purpura.Ann Oncol. 2008; 19: 1204-1207
- Management of cancer-associated thrombotic microangiopathy: what is the right approach?.Am J Hematol. 2007; 82: 295-298
- Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma.Cancer. 1993; 71: 1882-1892
- Gemcitabine-associated thrombotic thrombocytopenic purpura.Lancet Oncol. 2007; 8: 634-641
- Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.J Clin Oncol. 1985; 3: 723-734
- Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution.Ann Hematol. 2005; 84: 110-114
- Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes.Bone Marrow Transplant. 2001; 27: 641-646
- The management of malignant ureteral obstruction treated with ureteral stents.J Urol. 2005; 174: 2125-2128
- Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes.J Urol. 2008; 180: 444-450
- Malignant ureteral obstruction: outcomes after intervention. Have things changed?.J Urol. 2007; 178 ([discussion: 183]): 178-183
- Current therapy of myeloma induced renal failure.Leuk Lymphoma. 2008; 49: 833-834
- Review of 1027 patients with newly diagnosed multiple myeloma.Mayo Clin Proc. 2003; 78: 21-33
- Renal failure in multiple myeloma: incidence, correlations, and prognostic significance.Leuk Lymphoma. 2007; 48: 337-341
- Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group.Eur J Haematol. 2000; 65: 175-181
- Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial.Ann Intern Med. 2005; 143: 777-784
- Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.Clin J Am Soc Nephrol. 2009; 4: 745-754
- Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein.J Clin Invest. 1997; 99: 732-736
- Renal lesions associated with plasma cell dyscrasias: practical approach to diagnosis, new concepts, and challenges.Arch Pathol Lab Med. 2009; 133: 249-267
- Acute renal problems in the critically ill cancer patient.Curr Opin Crit Care. 2008; 14: 635-646
- Multiple myeloma.N Engl J Med. 2004; 351: 1860-1873
- Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.Eur J Haematol. 2004; 73: 98-103
- Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens.Leuk Lymphoma. 2008; 49: 890-895
- Reversal of dialysis-dependent renal failure in light-chain deposition disease by autologous peripheral blood stem cell transplantation.Am J Kidney Dis. 2004; 44: 551-555
- Long-term outcome of autologous stem cell transplantation in light chain deposition disease.Nephrol Dial Transplant. 2008; 23: 2052-2057
- Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study.J Clin Oncol. 2005; 23: 4406-4413
- Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model.J Clin Oncol. 1998; 16: 761-770
- Outcome for cancer patients requiring mechanical ventilation.J Clin Oncol. 1999; 17: 991-997
- Hope, truth, and preparing for death: perspectives of surrogate decision makers.Ann Intern Med. 2008; 149: 861-868
- Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.JAMA. 2008; 300: 1665-1673
- Factors considered important at the end of life by patients, family, physicians, and other care providers.JAMA. 2000; 284: 2476-2482
- Advance directives. Stability of patients' treatment choices.Arch Intern Med. 1994; 154: 209-217
- Talking with terminally ill patients and their caregivers about death, dying, and bereavement: is it stressful? Is it helpful?.Arch Intern Med. 2004; 164: 1999-2004
- End-of-life decisions in cancer care.Crit Care Clin. 2001; 17: 805-811
- The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation.Crit Care Med. 2007; 35: 808-814
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
